Acadia Healthcare Co Q2 2024 Adj. EPS $0.91 Beats $0.87 Estimate, Sales $796.040M Beat $784.448M Estimate
Portfolio Pulse from Benzinga Newsdesk
Acadia Healthcare Co (NASDAQ: ACHC) reported Q2 2024 adjusted EPS of $0.91, beating the estimate of $0.87. Sales were $796.040M, surpassing the $784.448M estimate and showing an 8.85% increase from the same period last year.
July 31, 2024 | 8:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acadia Healthcare Co reported better-than-expected Q2 2024 earnings and sales, with EPS of $0.91 beating the $0.87 estimate and sales of $796.040M surpassing the $784.448M estimate. This indicates strong financial performance and growth.
The better-than-expected earnings and sales figures indicate strong financial performance and growth for Acadia Healthcare Co. This positive news is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100